Correlation Between Uniroyal Global and Integrated Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Uniroyal Global and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Uniroyal Global and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Uniroyal Global Engineered and Integrated Biopharma, you can compare the effects of market volatilities on Uniroyal Global and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Uniroyal Global with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Uniroyal Global and Integrated Biopharma.

Diversification Opportunities for Uniroyal Global and Integrated Biopharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Uniroyal and Integrated is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Uniroyal Global Engineered and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Uniroyal Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Uniroyal Global Engineered are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Uniroyal Global i.e., Uniroyal Global and Integrated Biopharma go up and down completely randomly.

Pair Corralation between Uniroyal Global and Integrated Biopharma

If you would invest  0.03  in Uniroyal Global Engineered on September 2, 2024 and sell it today you would earn a total of  0.05  from holding Uniroyal Global Engineered or generate 166.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.4%
ValuesDaily Returns

Uniroyal Global Engineered  vs.  Integrated Biopharma

 Performance 
       Timeline  
Uniroyal Global Engi 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Uniroyal Global Engineered has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, Uniroyal Global is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Integrated Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Uniroyal Global and Integrated Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Uniroyal Global and Integrated Biopharma

The main advantage of trading using opposite Uniroyal Global and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Uniroyal Global position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.
The idea behind Uniroyal Global Engineered and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios